Discover the full management transaction log of 경동제약, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Market capitalisation: €146.7bn. The latest transaction was reported on 4 March 2026 (Purchase). Among the most active insiders: 류 기 성. All data is openly available.